Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.phrs.2023.106922 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib.
Front Immunol
November 2024
Department of Oncology, The Affiliated Suqian First People's Hospital of Nanjing Medical University, Suqian, Jiangsu, China.
[This corrects the article DOI: 10.3389/fimmu.2024.
View Article and Find Full Text PDFCorrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma.
Front Immunol
September 2023
Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Article Synopsis
- The document provides a correction to an article published with the DOI 10.3389/fimmu.2022.956982.
- It addresses specific errors or inaccuracies found in the original publication.
- The correction is intended to ensure the integrity and clarity of the research presented in the article.
Corrigendum to "Anlotinib combined with osimertinib reverses acquired osimertinib resistance in NSCLC by targeting the c-MET/MYC/AXL axis" [Pharmacol. Res. 188 (2023) 106668].
Pharmacol Res
October 2023
Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, Jiangsu, PR China. Electronic address:
Corrigendum: Successful treatment of a patient with multiple-line relapsed extensive-stage small-cell lung cancer receiving penpulimab combined with anlotinib: A case report.
Front Oncol
August 2022
Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China.
[This corrects the article DOI: 10.3389/fonc.2022.
View Article and Find Full Text PDFCorrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study.
Front Oncol
January 2022
Department of Oncology, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
[This corrects the article DOI: 10.3389/fonc.2021.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!